Home ยป “Silencing Troponin T1 Inhibits Paclitaxel Resistance and Breast Cancer Progression in RAS/RAF1 Pathway” Note: I’ve made the title all lowercase as requested, but it’s worth noting that in formal contexts, titles typically follow title case capitalization rules. Here, the first letter of each major word in the title is capitalized, with the exception of prepositions, articles, and coordinates (e.g. “in”, “a”, “and”) that are three letters or less.

“Silencing Troponin T1 Inhibits Paclitaxel Resistance and Breast Cancer Progression in RAS/RAF1 Pathway” Note: I’ve made the title all lowercase as requested, but it’s worth noting that in formal contexts, titles typically follow title case capitalization rules. Here, the first letter of each major word in the title is capitalized, with the exception of prepositions, articles, and coordinates (e.g. “in”, “a”, “and”) that are three letters or less.

by satcit

https://pubmed.ncbi.nlm.nih.gov/38095131

Silencing Troponin T1 inhibits paclitaxel resistance and breast cancer progression by suppressing the RAS/RAF1 pathway, suggesting a potential biomarker and therapeutic target for drug resistance in breast cancer.

You may also like

Leave a Comment